- Previous Close
555.00 - Open
560.00 - Bid 560.00 x --
- Ask 565.00 x --
- Day's Range
555.00 - 570.00 - 52 Week Range
515.00 - 780.00 - Volume
14,685,300 - Avg. Volume
18,135,792 - Market Cap (intraday)
16.8T - Beta (5Y Monthly) 0.16
- PE Ratio (TTM)
14.35 - EPS (TTM)
39.03 - Earnings Date Apr 23, 2025 - Apr 28, 2025
- Forward Dividend & Yield 36.00 (6.43%)
- Ex-Dividend Date Nov 5, 2024
- 1y Target Est
669.17
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through Herbal Medicine and Supplements, Food and Beverage, and Pharmacy segments. It also offers ethical and OTC products for various health interests, including ache and pain relief, antibiotics, anemia, anti-allergy, antioxidants, blood pressure, brain function, bone health, children's health, cold, flu, and cough, as well as diabetes, digestion, energy and vitality, heart and cholesterol, immune system, joints and mobility, liver and detox, men's health, skin health, sleep aids, tumor and cancer, weight management, women's health, and others. In addition, it is involved in commerce, land transportation, wastewater treatment, and plantation and printing activities. The company was founded in 1940 and is headquartered in Semarang, Indonesia. PT Industri Jamu dan Farmasi Sido Muncul Tbk is a subsidiary of PT Hotel Candi Baru.
www.sidomuncul.co.id3,564
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SIDO.JK
View MorePerformance Overview: SIDO.JK
Trailing total returns as of 3/27/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SIDO.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SIDO.JK
View MoreValuation Measures
Market Cap
16.80T
Enterprise Value
15.95T
Trailing P/E
14.35
Forward P/E
13.50
PEG Ratio (5yr expected)
4.22
Price/Sales (ttm)
4.29
Price/Book (mrq)
4.82
Enterprise Value/Revenue
4.07
Enterprise Value/EBITDA
10.47
Financial Highlights
Profitability and Income Statement
Profit Margin
29.88%
Return on Assets (ttm)
23.68%
Return on Equity (ttm)
34.07%
Revenue (ttm)
3.92T
Net Income Avi to Common (ttm)
1.17T
Diluted EPS (ttm)
39.03
Balance Sheet and Cash Flow
Total Cash (mrq)
855.57B
Total Debt/Equity (mrq)
0.10%
Levered Free Cash Flow (ttm)
829.26B